Efficacy Data Evaluation

Efficacy Data Evaluation is a systematic scientific assessment within regulatory pharmacology that analyzes clinical and non-clinical evidence to determine the therapeutic performance of a medical product under idealized conditions, distinguishing it from safety or pharmacokinetic evaluations by focusing specifically on the magnitude and consistency of clinically meaningful outcomes.

715

Publications

41.3K

Citations

5.9K

Authors

2.2K

Institutions

Publications per year

2017–2026

286

Authors

5.9K

  1. DR
    D. Ross Camidge

    University of Colorado Denver, United States

    7 publications · 550 citations

    7

    h-index

  2. PJ
    Philip J. Mease

    University of Washington, United States

    4 publications · 418 citations

    4

    h-index

  3. GS
    Gerald S. Falchook

    The University of Texas MD Anderson Cancer Center, United States

    4 publications · 659 citations

    4

    h-index

  4. JM
    Johnny Mahlangu

    University of the Witwatersrand, South Africa

    4 publications · 202 citations

    4

    h-index

  5. TR
    Thomas R. Fleming

    University of Washington, United States

    4 publications · 162 citations

    4

    h-index

1–5 of 5.9K

Venues

  1. Journal of Clinical Oncology

    90 publications · 5.3K citations

    31

    h-index

  2. PubMed

    Repository · 36 publications · 1.7K citations

    20

    h-index

  3. Statistics in Medicine

    14 publications · 461 citations

    13

    h-index

  4. Clinical Cancer Research

    8 publications · 494 citations

    8

    h-index

  5. PLoS ONE

    7 publications · 286 citations

    7

    h-index

1–5